182 related articles for article (PubMed ID: 16234048)
1. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
Matula S; Croog V; Itzkowitz S; Harpaz N; Bodian C; Hossain S; Ullman T
Clin Gastroenterol Hepatol; 2005 Oct; 3(10):1015-21. PubMed ID: 16234048
[TBL] [Abstract][Full Text] [Related]
2. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.
Ullman T; Croog V; Harpaz N; Hossain S; Kornbluth A; Bodian C; Itzkowitz S
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1225-30; quiz 1177. PubMed ID: 18848502
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
[TBL] [Abstract][Full Text] [Related]
4. Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.
Rubin DT; Huo D; Kinnucan JA; Sedrak MS; McCullom NE; Bunnag AP; Raun-Royer EP; Cohen RD; Hanauer SB; Hart J; Turner JR
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1601-8.e1-4. PubMed ID: 23872237
[TBL] [Abstract][Full Text] [Related]
5. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
6. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.
Gupta RB; Harpaz N; Itzkowitz S; Hossain S; Matula S; Kornbluth A; Bodian C; Ullman T
Gastroenterology; 2007 Oct; 133(4):1099-105; quiz 1340-1. PubMed ID: 17919486
[TBL] [Abstract][Full Text] [Related]
7. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
[TBL] [Abstract][Full Text] [Related]
8. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview.
Choi CH; Rutter MD; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Graham TA; Hart AL
Am J Gastroenterol; 2015 Jul; 110(7):1022-34. PubMed ID: 25823771
[TBL] [Abstract][Full Text] [Related]
9. Azathioprine: state of the art in inflammatory bowel disease.
Sandborn WJ
Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
[TBL] [Abstract][Full Text] [Related]
10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
Allgayer H; Kruis W
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):521; author reply 521. PubMed ID: 16616360
[No Abstract] [Full Text] [Related]
12. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.
Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S
Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678
[TBL] [Abstract][Full Text] [Related]
14. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Gastrointest Endosc; 2011 Nov; 74(5):1087-93. PubMed ID: 21907984
[TBL] [Abstract][Full Text] [Related]
15. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
16. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
[TBL] [Abstract][Full Text] [Related]
17. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis.
Ullman T; Croog V; Harpaz N; Sachar D; Itzkowitz S
Gastroenterology; 2003 Nov; 125(5):1311-9. PubMed ID: 14598247
[TBL] [Abstract][Full Text] [Related]
18. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
19. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of colorectal cancer in ulcerative colitis.
Croog VJ; Ullman TA; Itzkowitz SH
Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
